A phytochemical investigation of the acetone extract from the aerial parts of Leucas mollissima afforded one new (−)epi-marmelo lactone, (2 S, 4R, 6 S)-2,6-dimethyl-6 hydroxy-7-ene-4-olide (1), along with five known compounds, schensianol A (2), vanillin (3), β-hydroxy propiovanillone (4), lanost-9(11),25-diene-3β,24β-diol (5), and lanost-9(11),23E(24)-diene-3β,25-diol (6). Similarly, an investigation of the methanol extract of the aerial parts of L. mollissima resulted in the isolation of three known compounds, (+)-syringaresinol (7), anisofolin A (8), and apigenin 7-O-β-D(− 6′′-p-E-coumaroyl)-glucoside (9). Structure elucidation of the isolated compounds was carried out using detailed analysis of 1D and 2D nuclear magnetic resonance. All compounds were evaluated for antimalarial activity against Plasmodium falciparum (3D7) and for antimycobacterium activity against Mycobacterium tuberculosis H37Ra and Mycobacterium bovis. Compound 8 was found to have promising antimalarial activity (IC 50 4.39 ± 0.25 µM), promising antimycobacterium activity [IC 50 4.50 ± 0.75 µM (3.31 µg/mL)] against M. tuberculosis H37Ra and at 100 µg/mL, showed 55.6 % inhibition of M. bovis. Compound 9 showed moderate inhibition of P. falciparum growth (35% inhibition at 10 µM) with respect to the positive control atovaquone and 67.4 % inhibition against M. bovis at 100 µg/mL with respect to the positive control rifampicin.
The genus Leucas from the family Lamiaceae comprises about 80 species [1] . In India, 43 species are available [2] , of which 21 are found in the state of Maharashtra [3] . Plants of the genus Leucas have been widely employed by traditional healers to cure many disease conditions, which suggests that this genus has potential for the discovery of new drugs or lead molecules [1] . Leucas mollissima Wall. is distributed in India in the western peninsular, subtropical Himalayan region, and in the states of West Bengal and Orissa [4] . The juice from the leaf of this herb is applied externally to treat ailments relating to headache, while the decoction has been used orally to treat diabetes mellitus and liver diseases such as hepatitis [5] . In our continuing efforts to isolate bioactive compounds from plants found in the Western Ghats of Maharashtra for the development of new drugs active against infectious diseases such as malaria and tuberculosis, we report herein the isolation and structure elucidation of compound 1, (−)epi-marmelo lactone, a new natural product, along with eight known compounds (2-9) (l " Fig. 1 ). Compounds 8 and 9 were evaluated for antimalarial activity against Plasmodium falciparum (3D7) and antimycobacterium activity against Mycobacterium tuberculosis H37Ra and Mycobacterium bovis. Compound 1 was isolated as yellow gum. The molecular formula was determined as C 10 H 16 O 3 from HR-ESI-MS ( Fig. 1 S, Supporting Information), which showed a pseudo-molecular peak at 207.0991 [M + Na] + indicating three indices of hydrogen deficiency. This was supported by 13 Table 1 ) and DEPT-135 ( Fig. 4 S, Supporting Information) spectra showed the presence of two methyls, three methylenes, three methines, and two quaternary carbons. Methylene at δ H 5.16-5.34 (δ C 112.9) and methine at δ H 5.94 (δ C 143.9) indicated the presence of a double bond as an olefinic end group, and one quaternary carbon at δ C 179.4 showed the presence of a lactone carbonyl carbon. These data indicated 1 to be a monocyclic compound belonging to the lactone class. The structure of 1 was assigned by 2D NMR as follows: A proton at δ H 2.69 (δ C 33.8, H-2) and protons at δ H 2.11 and 2.05 (δ C 36.5, H 2 -3) showed a heteronuclear multiple bond correlation (HMBC; Fig. 6 S, Supporting Information) with a carbonyl at δ C 179.4 (C-1) indicating that there was a lactone ring with one methine and one methylene. Protons at δ H 1.98 and 1.80 (δ C 46.9, H 2 -5) showed an HMBC correlation with a carbon at δ C 75.8 (δ H 4.76, C-4) and with a quaternary carbon at δ C 72.6 (C-6). Protons at δ H 5.94 (δ C 143.9, H 1 -7), 5.34, and 5.16 (δ C 112.9, H 2 -8) showed an HMBC correlation with a carbon at δ C 72.6 (C-6). Similarly, the proton at δ H 1.35 (δ C 28.7, H 3 -10) showed an HMBC correlation with an unsaturated carbon at δ C 143.9 (δ H 5.94, C-7). These observations confirmed the presence of a side chain with an olefinic end group. The key HMBC correlations are shown in l " Fig. 2 . Correlation spectroscopy (COSY; Fig. 7 S, Supporting Information) correlations observed between δ H 1.30 (H 3 -9) and 2.69 (H-2), δ H 2.69 (H-2) and 2.11 (H 2 -3), δ H 2.11 (H 2 -3) and 4.76 (H-4), and δ H 4.76 (H-4) and 1.80-1.98 (H 2 -5) supported the structure of 1 to be a lactone with a side chain (l " Fig. 2 ). The nuclear Overhauser effect spectroscopy (NOESY; Fig. 8 Fig. 2 ). Compound 1 was found to have a negative specific rotation ([α] D 26 : − 81.90). Thus, 1 was found to be an epimer of the previously isolated and structurally similar marmelo lactone from the fruit of Cydonia oblonga Mill. (Rosaceae) [6] , and hence identified as a new natural product, (2 S, 4R, 6 S)-2,6-dimethyl-6 hydroxy-7ene-4-olide, belonging to the class of (−) epi-marmelo lactones. Compound 2 was identified as schensianol A by comparing its NMR data from a previously reported article in which it was isolated from Euonymus schensianus Maxim. (Celastraceae) [7] . Compounds 3 and 4 were identified as vanillin and β-Hydroxy propiovanillone, respectively, by comparing their NMR data with Letter THIEME those available in the literature [8, 9] . Compound 5 was identified as a lanost-9(11),25-diene-3β,24β-diol and compound 6 was identified to be a lanost-9(11),23E(24)-diene-3β,25-diol by comparison of literature NMR data and mass spectra reported for compounds isolated from Mulgedium tataricum (L.) DC. (Asteraceae) [10, 11] . Compound 7 was identified as (+) syringaresinol by comparing its NMR data with those available in the literature [12] . Compound 8 was identified as apigenin 7-O-β-D(-3′′,6′′-p-E-dicoumaroyl)-glucoside, Anisofolin A, by comparing its spectral data with those available in literature [13] [14] [15] . Compound 9 was identified as apigenin 7-O-β-D-(-6′′-p-E-coumaroyl)-glucoside by comparing its spectral data with the literature [16, 17] .
Material and Methods

!
General experimental procedures, chemicals, and biochemicals: Optical rotations were measured using a JASCO P-1020 polarimeter. The 1 H and 13 Biological screenings: Antimalarial screening: A primary screening for compounds 1-9 was done as per standard protocols [18] at the 10 µM concentration, and for the crude mixture, a 1 µg/mL concentration was used. Protocol details are given in Supporting Information. Compound 8 was found to have significant antimalarial activity and was capable of completely inhibiting parasite growth at the 10 µM concentration. The IC 50 was found to be 4.39 ± 0.25 µM compared to the positive control atovaquone, as shown in l " Table 2 . However, compound 9 had only a moderate effect on parasite growth. Antimycobacterial screening: Compounds 1-9 were evaluated for their in vitro inhibition effect against M. tuberculosis H37Ra (ATCC No. 25 177) using the XTT Reduction Menadione Assay protocol and M. bovis (ATCC No. 35 745) using the Nitrate Reductase assay protocol [19] [20] [21] . Protocol details are given in Supporting Information. Compound 8 was found to be active with an IC 50 of 4.50 ± 0.75 µM (3.31 µg/mL) against M. tuberculosis H37Ra compared to the positive control rifampicin, with an IC 50 of 0.0019 ± 0.0003 µg/mL. Compounds 8 and 9 at the 100 µg/mL concentration showed growth inhibition of 55.6 % and 67.4 %, respectively, against M. bovis.
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